Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Stereotactic Radiotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05459311
What this trial is testing

Investigating Radiation-Induced Injury to Airways and Pulmonary Vasculature in Lung Stereotactic Ablative Body Radiotherapy (SAbR)

Who this might be right for
Lung CancerThoracic Cancer
University of Texas Southwestern Medical Center 12
Testing effectiveness (Phase 2)UnknownNCT02584699
What this trial is testing

Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Luhua Wang 40
Testing effectiveness (Phase 2)UnknownNCT05588206
What this trial is testing

Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerStage IV Non-small Cell Lung CancerBrain Metastases
First People's Hospital of Hangzhou 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07818304
What this trial is testing

SRT Combined With Envafolimab and Endostar in the First-line Treatment of Advanced NSCLC

Who this might be right for
Non Small Cell Lung CancerLung Neoplasms
The First People's Hospital of Lianyungang 61
Post-approval studies (Phase 4)Looking for participantsNCT07754812
What this trial is testing

Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLC

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Shanghai Pulmonary Hospital, Shanghai, China 78
Early research (Phase 1)WithdrawnNCT00818714
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) as a Boost After Definitive Concurrent Chemoradiation (ChemoRT) for Non-Small Cell Lung Cancer (NSCLC) GCC 0516

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
University of Maryland, Baltimore
Early research (Phase 1)Study completedNCT01899989
What this trial is testing

Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center 39
Very early researchEnded earlyNCT01525446
What this trial is testing

Proton Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Massachusetts General Hospital 7
Large-scale testing (Phase 3)Not Yet RecruitingNCT07289646
What this trial is testing

Functional Lung Avoidance Planning Guided by Lung Perfusion PET/CT Versus Anatomical Planning for Lung Stereotactic Body Radiotherapy

Who this might be right for
Stereotactic Body Radiotherapy68Ga-MAALung Cancer (Diagnosis)
University Hospital, Brest 418
Large-scale testing (Phase 3)UnknownNCT01130766
What this trial is testing

Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Samsung Medical Center 176
Early research (Phase 1)Ended earlyNCT02187822
What this trial is testing

Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases

Who this might be right for
Brain MetastasesGeneralized Malignancy, PrimaryBrain Lesions
H. Lee Moffitt Cancer Center and Research Institute 15
Testing effectiveness (Phase 2)Study completedNCT03004183
What this trial is testing

SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLC

Who this might be right for
Metastatic Non-small Cell Lung CancerMetastatic Triple-negative Breast Cancer
The Methodist Hospital Research Institute 57
Testing effectiveness (Phase 2)UnknownNCT03153358
What this trial is testing

Icotinib Combined With SBRT for Patients With Metastatic Non-squamous NSCLC With EGFR Mutation

Who this might be right for
Lung Cancer Stage IV
Sichuan Cancer Hospital and Research Institute 60
Testing effectiveness (Phase 2)Study completedNCT02839265
What this trial is testing

FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Montefiore Medical Center 33
Testing effectiveness (Phase 2)Ended earlyNCT00121420
What this trial is testing

Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases

Who this might be right for
Neoplasm MetastasisBrain Neoplasms
Pharmacyclics LLC. 45
Large-scale testing (Phase 3)Looking for participantsNCT05236946
What this trial is testing

Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT

Who this might be right for
Asymptomatic Brain MetastasesDriver Mutation Positive Non-small Cell Lung Cancer
Tata Memorial Hospital 190
Testing effectiveness (Phase 2)Looking for participantsNCT06730295
What this trial is testing

Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Centrally Located Early-stage Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer (NSCLC)
Sun Yat-sen University 52
Large-scale testing (Phase 3)Study completedNCT01968941
What this trial is testing

Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients

Who this might be right for
Non-small Cell Lung Cancer
Ontario Clinical Oncology Group (OCOG) 324
Testing effectiveness (Phase 2)Study completedNCT01573702
What this trial is testing

Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)

Who this might be right for
Non Small Cell Lung Cancer
UNC Lineberger Comprehensive Cancer Center 32
Not applicableStudy completedNCT01051037
What this trial is testing

Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central Airways

Who this might be right for
Lung Cancer
Jonsson Comprehensive Cancer Center 17
Next Page